Course summary
This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process. It addresses key aspects of preclinical drug evaluation through the study of:
- Drug discovery and development
- Safety pharmacology
- Mechanisms of drug-induced toxicities
- Regulatory affairs
- Bioanalytical sciences
Entry requirements
2:1 or above Honours degree in Biological Sciences, Chemical Sciences, Pharmacy, Pharmacology or Pharmaceutical Sciences. Candidates with a 2:2 Honours degree and relevant experience will be considered on an individual basis. English language requirements: IELTS at 6.0 or equivalent level qualification
Fees and funding
Tuition fees
England | £9230 | Whole course |
Northern Ireland | £9230 | Whole course |
Scotland | £9230 | Whole course |
Wales | £9230 | Whole course |
Republic of Ireland | £9230 | Whole course |
EU | £23028 | Whole course |
International | £23028 | Whole course |
Channel Islands | £23028 | Whole course |
Tuition fee status depends on a number of criteria and varies according to where in the UK you will study. For further guidance on the criteria for home or overseas tuition fees, please refer to the UKCISA website .
Additional fee information
Provider information
University of Bradford
Richmond Road
Bradford
BD7 1DP